Evaluation of a randomised-controlled cognitive-behavioural individual therapy for patients with somatoform disorders

Psychological Institute, University of Mainz (Germany)0 个研究点目标入组 60 人开始时间: 2007年5月2日最近更新: 2017年7月3日

适应症

试验速览

暂无简介。

•1. The presence of a somatoform disorder (Somatic Symptom Inventory [SSI] 3 - patients with at least three current Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition [DSM IV] somatoform symptoms)
•2. The somatoform disorder is the main treatment issue (co-morbidities are allowed)
•3. Indication for individual therapy
•4. Age 18-65
•5. Written informed consent

•1. Age: under 18, over 65 years
•2. Ongoing psychological treatment
•3. Treatment in a psychiatric hospital during the last 5 years
•4. Acute psychotic or manic symptoms
•5. Substance dependency
•6. Severe depression, suicidal thoughts or behaviours
•7. Post Traumatic Stress Disorder (PTSD) and personality disorder (clusters A & B)
•8. Dementia or neurodegenerative disorders
•9. Unable to understand German language
•10. Request of early retirement because of somatoform disorder

发起方

Psychological Institute, University of Mainz (Germany)